-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adipose Tissue Derived Mesenchymal Stromal/Stem...
-
Product Insights
Chapais Biomass Power Plant
Chapais Biomass Power Plant is a biopower project located in Quebec, Canada. The project is owned by Chapais Energie and was developed by HMI Construction Inc. The project came online in 1995. Empower your strategies with our Chapais Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inobrodib in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inobrodib in Refractory Acute Myeloid Leukemia Drug Details: Inobrodib (CCS-1477) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XmAb-968 in Multiple Myeloma (Kahler Disease)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. XmAb-968 in Multiple Myeloma (Kahler Disease) Drug Details: XmAb-698 (AMG-424) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – REGN-5459 in Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - REGN-5459 in Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.REGN-5459 in Transplant Rejection Drug Details:REGN-5459 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SCO-120 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SCO-120 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SCO-120 in Breast Cancer Drug Details:SCO-120 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Monoclonal Antibody To Inhibit Pcsk9 For Inflammation And Metabolic Disorders in Inflammation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Monoclonal Antibody To Inhibit Pcsk9 For Inflammation And Metabolic Disorders in Inflammation Drug Details:Monoclonal antibody is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4381562 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4381562 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GSK-4381562 in Gastric Cancer Drug Details:GSK4381562 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Peanut Allergy in Peanut Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Peanut Allergy in Peanut Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Allergen For Peanut Allergy in Peanut Allergy Drug Details:Allergen is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amivantamab in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amivantamab in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amivantamab in Metastatic Colorectal Cancer Drug Details: Amivantamab-vmjw (Rybrevant) is a...